Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Unichem Laboratories LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:506690NSE Symbol: UNICHEMLABP/E(TTM):26.32
ISIN Demat:INE351A01035Div & Yield %:0EPS(TTM):22.64
Book Value(Rs):349.3679351Market Cap ( Cr.):4194.77Face Value(Rs):2
    Change Company 
( In Cr)
 Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
INCOME :      
Sales Turnover 1735.701442.161072.43942.931123.97904.44
Excise Duty0.000.000.000.000.000.00
Net Sales1735.701442.161072.43942.931123.97904.44
Other Income 44.8398.4041.8542.0747.3799.17
Stock Adjustments 33.3326.35-22.0152.7916.7318.50
Total Income1813.861566.911092.271037.791188.071022.11
EXPENDITURE :      
Raw Materials 830.62717.82501.86436.27449.67401.25
Power & Fuel Cost106.63105.64101.4177.1267.9572.14
Employee Cost 287.51283.15270.86250.79234.04205.16
Other Manufacturing Expenses 78.1074.6270.6173.4964.4868.09
Selling and Administration Expenses 190.81213.59194.89192.65225.80263.43
Miscellaneous Expenses 21.48148.40116.368.953.283.48
Less: Pre-operative Expenses Capitalised0.000.000.000.000.000.00
Total Expenditure1515.151543.221256.001039.271045.231013.55
Operating Profit298.7123.69-163.73-1.49142.848.56
Interest 7.6210.429.382.071.301.28
Gross Profit291.0913.27-173.11-3.56141.547.28
Depreciation108.41105.45105.9883.1975.8971.09
Profit Before Tax182.68-92.18-279.09-86.7565.65-63.81
Tax0.000.000.000.000.000.00
Fringe Benefit tax0.000.000.000.000.000.00
Deferred Tax19.720.0020.61-31.3211.56-7.50
Reported Net Profit162.96-92.18-299.70-55.4354.08-56.32
Extraordinary Items 4.42-55.94-103.16-0.250.02-1.45
Adjusted Net Profit158.54-36.24-196.54-55.1854.06-54.87
Adjst. below Net Profit 0.000.00121.810.000.000.00
P & L Balance brought forward2279.182359.312565.362648.962623.042712.21
Statutory Appropriations 0.000.000.000.000.000.00
Appropriations -2.89-12.0528.1628.1628.1632.85
P & L Balance carried down2445.032279.182359.312565.362648.962623.04
Dividend0.000.000.000.000.000.00
Preference Dividend0.000.000.000.000.000.00
Equity Dividend %0.000.00200.00200.00200.00200.00
Earnings Per Share-Unit Curr23.15-13.09-42.57-7.877.68-8.00
Earnings Per Share(Adj)-Unit Curr23.15-13.09-42.57-7.877.68-8.00
Book Value-Unit Curr349.40325.94338.65379.52383.11375.99